⋮
0
0
European Commission Approves ALUNBRIG® (brigatinib) for ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib, Advancing Treatment Paradigm in Europe
Showing live article 1109 of 3352 in channel 19681208
Article Details:
Author:
Language: Japanese
Channel Number: 19681208
Article Number: 1109
Date: November 26, 2018, 8:00 pm
URL: http://www.qlifepro.com/press/20181127-22-37954/ma-takeda-pharmaceutical-91/
GUID: http://www.qlifepro.com/press/?p=37954
←
$
..going to article 1109
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL